AegirBio AB

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: SE0014401121

SEK

0.05

0 (6.06%)

Jun 25

OME

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arcoma AB

Scandinavian ChemoTech AB

Kontigo Care AB

Inhalation Sciences Sweden AB

AegirBio AB

Duearity AB

Scandinavian Real Heart AB

BiBBInstruments AB

NeoDynamics AB

Coala Life Group AB

Bioservo Technologies AB

Why is AegirBio AB ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 0.41% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -14.00

Flat results in Sep 24

INTEREST(Q) At SEK 3.73 MM has Grown at inf%
RAW MATERIAL COST(Y) Grown by 101.01% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 1650.00%, its profits have risen by 45.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is AegirBio AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

AegirBio AB

1650.0%

-0.00

76937.40%

OMX Stockholm 30

28.68%

1.80

15.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

0.41%

EBIT to Interest (avg)

-14.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.14

Sales to Capital Employed (avg)

0.01

Tax Ratio

2.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.01

EV to EBIT

-0.80

EV to EBITDA

-0.80

EV to Capital Employed

8.28

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-1029.83%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Bearish

OBV

No Trend

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for AegirBio AB

Interest

At SEK 3.73 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Raw Material Cost

Grown by 101.01% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales